Idera Pharmaceuticals Inc: Diferență între versiuni

Pagină nouă: Pagina dedicata companiei Idera Pharmaceuticals Inc listata cu simbolul US.IDRA ==Descriere companie== Idera Pharmaceuticals, Inc. (http://www.iderapharma.com/) is a clinical-stage biopharmaceutical company focused on clinical development and commercialization of drug candidates for both oncology and rare disease. The Company is engaged on Toll-like receptor (TLR) agonist, tilsotolimod (IMO-2125), for oncology. It uses its chemistry-based platform to design both TLR agonists...
(Pagină nouă: Pagina dedicata companiei Idera Pharmaceuticals Inc listata cu simbolul US.IDRA ==Descriere companie== Idera Pharmaceuticals, Inc. (http://www.iderapharma.com/) is a clinical-stage biopharmaceutical company focused on clinical development and commercialization of drug candidates for both oncology and rare disease. The Company is engaged on Toll-like receptor (TLR) agonist, tilsotolimod (IMO-2125), for oncology. It uses its chemistry-based platform to design both TLR agonists...)
(Nicio diferență)